Welcome to our dedicated page for JPMORGAN CHASE & CO SEC filings (Ticker: JPM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on JPMORGAN CHASE & CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into JPMORGAN CHASE & CO's regulatory disclosures and financial reporting.
JPMorgan Chase & Co.'s Chief Information Officer Lori A. Beer reported an open-market sale of 3,166 shares of JPM common stock. The transaction was executed at a price of $306.5887 per share. Following this sale, she directly holds 69,948 shares of JPM common stock.
JPMorgan Chase & Co.'s Chief Financial Officer Jeremy Barnum sold shares in the company. On April 15, 2026, he completed an open-market sale of 5,611 shares of JPMorgan Chase & Co. common stock at a price of $306.5522 per share. After this transaction, he continued to hold 35,460 shares of the company’s common stock directly.
JPMorgan Chase & Co. Chief Risk Officer Ashley Bacon executed an open-market sale of 7,558 shares of Common Stock at an average price of $306.5535 per share. Following this transaction, Bacon directly holds 252,855 shares of JPMorgan Chase & Co. Common Stock.
JPMorgan Chase affiliate submitted a Form 144 reporting planned sales of Common Stock. The notice lists multiple grant- and award-related lots with transaction dates of 01/13/2026 and 03/25/2024, and references sale activity tied to an issuer-held equity compensation source.
JPMorgan Chase & Co. submitted a Form 144 notice relating to proposed and recent sales of Common Stock. The filing lists 5,660 shares identified for sale (acquired via equity awards) and reports two prior dispositions of 3,487 shares each on 01/16/2026 and 02/17/2026, with proceeds of $1,090,727.70 and $1,068,428.91 respectively. The securities are Common Stock, $1 par value and the exchange is listed as NYSE.
J.P. Morgan reported proposed sales of Common Stock by Marianne Lake under Form 144. The filing lists a sale of 3,908 shares on 01/16/2026 with proceeds of $1,222,353.41 and a sale of 3,907 shares on 02/17/2026 with proceeds of $1,197,158.15.
The form also lists equity compensation acquisitions dated 01/13/2022, 01/13/2024, and 01/13/2025 with counts shown in the excerpt.
J.P. Morgan (JPM) filer Mary E. Erdoes reported proposed sales of Common Stock under Rule 144. The excerpt lists two reported transactions: 5,732 shares on 01/16/2026 for $1,792,878.56 and 5,731 shares on 02/17/2026 for $1,756,045.86. The filing also lists securities acquired as awards on 01/13/2011 (9,435 shares) and 01/13/2012 (2,910 shares).
Reporting person filed a Form 144 to notify the sale of Common Stock. The notice lists 3,166 shares of Common Stock acquired 01/13/2026 as securities to be sold and discloses prior dispositions of 2,047 shares on 01/16/2026 and 02/17/2026.
JPMorgan Chase & Co. filed a Form 144 notifying the sale of 5,611 shares of Common Stock pursuant to equity compensation awards, with prior sales of 2,893 shares on 01/16/2026 and 2,892 shares on 02/17/2026. The filing lists broker details for J.P. Morgan Securities LLC and cash amounts tied to the past sales.
Insider sale reported: Ashley Bacon reported the sale of 7,364 shares of Common Stock on 01/16/2026 through J.P. Morgan Securities LLC, generating proceeds of $2,303,393.28. The filing also lists prior equity awards: 192 shares acquired 03/25/2024 and 7,366 shares acquired 01/13/2026.